{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T05:07:39Z","timestamp":1697864859365},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jad-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jad.2013.05.027","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T10:16:33Z","timestamp":1370513793000},"page":"1197-1199","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Valproate as a risk factor for lamotrigine discontinuation"],"prefix":"10.1016","volume":"150","author":[{"given":"Yasuhisa","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setsuko","family":"Yasugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenshiro","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Terao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2013.05.027_bib1","first-page":"27","article-title":"Rechallenge with lamotrigine after a rash: a prospective case series and review of the literature","volume":"7","author":"Aiken","year":"2010","journal-title":"Psychiatry"},{"key":"10.1016\/j.jad.2013.05.027_bib2","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1528-1167.2011.03217.x","article-title":"The effect of age and comedication on lamotrigine clearance, tolerability, and efficacy","volume":"52","author":"Arif","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jad.2013.05.027_bib3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2013.05.027_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0447.2012.01890.x","article-title":"Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo-controlled maintenance treatment for bipolar depression","volume":"126","author":"Bowden","year":"2012","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jad.2013.05.027_bib5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2013.05.027_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","article-title":"Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials","volume":"10","author":"Calabrese","year":"2008","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2013.05.027_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.pnpbp.2005.11.033","article-title":"Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder","volume":"30","author":"Chang","year":"2006","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.jad.2013.05.027_bib8","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.pnpbp.2008.06.006","article-title":"Lamotrigine might potentiate valproic acid-induced hyperammonemic encephalopathy","volume":"32","author":"Fan","year":"2008","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.jad.2013.05.027_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"194","author":"Geddes","year":"2009","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2013.05.027_bib10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v65n0321","article-title":"A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder","volume":"65","author":"Goodwin","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2013.05.027_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jpsychires.2008.02.007","article-title":"Effectiveness of lamotrigine in bipolar disorder in a clinical setting","volume":"43","author":"Ketter","year":"2009","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jad.2013.05.027_bib12","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1365-4632.2008.03827.x","article-title":"Anticonvulsant hypersensitivity syndrome: clinical and laboratory features","volume":"47","author":"Mansur","year":"2008","journal-title":"International Journal of Dermatology"},{"key":"10.1016\/j.jad.2013.05.027_bib13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1212\/WNL.51.4.1172","article-title":"Lamotrigine-associated anticonvulsant hypersensitivity syndrome","volume":"51","author":"Schlienger","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2013.05.027_bib14","first-page":"47","article-title":"Late adverse effects of the coadministration of valproate and lamotrigine","volume":"47","author":"Thome-Souza","year":"2012","journal-title":"Periodic Neurology"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032713003868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032713003868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T12:59:01Z","timestamp":1539608341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032713003868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0165032713003868"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2013.05.027","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproate as a risk factor for lamotrigine discontinuation","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2013.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}